To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Funerals: Regulation
Tuesday 24th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department is responsible for reforming the regulation of funeral directors.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.


Written Question
Radiotherapy: Artificial Intelligence
Tuesday 24th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 February 2025 to Question 27053 on Cancer: Health Services, how much funding his Department (a) has allocated and (b) plans to allocate to increase maximise radiotherapy productivity through AI.

Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.


Written Question
Health Services: Sports
Friday 20th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the exemption for temporary cultural and sporting events from laws mandating that medical providers be CQC registered for sporting events on the finances of that organisation.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.


Written Question
Health Professions: Culture and Sports
Thursday 19th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes removing exemptions for temporary cultural and sporting events from laws mandating that medical providers be CQC registered on the number of cultural and sporting events in England.

Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.


Written Question
Neurodiversity: Mental Health Services
Thursday 12th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will list all the (a) patient representative organisations, (b) clinical associations and (c) providers of NHS-funded autism and ADHD services NHS England has engaged with (i) before and (ii) since publishing proposed guide prices for autism and ADHD services in its 2026/27 payment scheme consultation, in respect of the prices proposed.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:

https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/

NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.

Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.

In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:

  • engagement with the Independent Healthcare Provider Network (IHPN), representing independent sector providers; and
  • engagement with healthcare policy professionals, clinicians, patient representative organisations, commissioners, and providers.

In addition, the following engagement took place on this policy area post-consultation:

  • further engagement with the IHPN, representing independent sector providers;
  • engagement with integrated care boards;
  • engagement with independent sector providers;
  • engagement with mental health trusts; and
  • engagement with clinicians.

NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:

  • the National Institute for Health and Care Excellence’s (NICE) clinical guidelines CG142, CG128, and CG170, and NICE’s quality standards, which are available at the following link: https://www.nice.org.uk/Guidance/QS51;
  • NHS England’s published National framework and operational guidance for autism assessment services, available at the following link: https://www.england.nhs.uk/publication/autism-diagnosis-and-operational-guidance/;
  • NHS England’s published reports of the ADHD taskforce, available at the following link: https://www.england.nhs.uk/mental-health/adhd/;
  • local integrated care board service specifications;
  • pricing information in a sample of contracts for provision of autism diagnostic assessment services and ADHD services; and
  • a number of relevant academic papers, including, in particular, Realist evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Findings from a rapid realist review, which contains autism diagnostic assessment costs.

Written Question
Neurodiversity: Mental Health Services
Thursday 12th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the difference in levels of healthcare resource consumed in conducting (a) children’s autism assessments and (b) children’s ADHD assessments; and what account of this assessment NHS England took in proposing guide prices for autism and ADHD services, as set out in its 2026/27 payment scheme consultation.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:

https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/

NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.

Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.

In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:

  • engagement with the Independent Healthcare Provider Network (IHPN), representing independent sector providers; and
  • engagement with healthcare policy professionals, clinicians, patient representative organisations, commissioners, and providers.

In addition, the following engagement took place on this policy area post-consultation:

  • further engagement with the IHPN, representing independent sector providers;
  • engagement with integrated care boards;
  • engagement with independent sector providers;
  • engagement with mental health trusts; and
  • engagement with clinicians.

NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:

  • the National Institute for Health and Care Excellence’s (NICE) clinical guidelines CG142, CG128, and CG170, and NICE’s quality standards, which are available at the following link: https://www.nice.org.uk/Guidance/QS51;
  • NHS England’s published National framework and operational guidance for autism assessment services, available at the following link: https://www.england.nhs.uk/publication/autism-diagnosis-and-operational-guidance/;
  • NHS England’s published reports of the ADHD taskforce, available at the following link: https://www.england.nhs.uk/mental-health/adhd/;
  • local integrated care board service specifications;
  • pricing information in a sample of contracts for provision of autism diagnostic assessment services and ADHD services; and
  • a number of relevant academic papers, including, in particular, Realist evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Findings from a rapid realist review, which contains autism diagnostic assessment costs.

Written Question
Neurodiversity: Mental Health Services
Thursday 12th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will list all the (a) academic papers and (b) other sources of evidence that NHS England has considered in setting its proposed guide prices for autism and ADHD services, as proposed in its 2026/27 payment scheme consultation.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:

https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/

NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.

Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.

In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:

  • engagement with the Independent Healthcare Provider Network (IHPN), representing independent sector providers; and
  • engagement with healthcare policy professionals, clinicians, patient representative organisations, commissioners, and providers.

In addition, the following engagement took place on this policy area post-consultation:

  • further engagement with the IHPN, representing independent sector providers;
  • engagement with integrated care boards;
  • engagement with independent sector providers;
  • engagement with mental health trusts; and
  • engagement with clinicians.

NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:

  • the National Institute for Health and Care Excellence’s (NICE) clinical guidelines CG142, CG128, and CG170, and NICE’s quality standards, which are available at the following link: https://www.nice.org.uk/Guidance/QS51;
  • NHS England’s published National framework and operational guidance for autism assessment services, available at the following link: https://www.england.nhs.uk/publication/autism-diagnosis-and-operational-guidance/;
  • NHS England’s published reports of the ADHD taskforce, available at the following link: https://www.england.nhs.uk/mental-health/adhd/;
  • local integrated care board service specifications;
  • pricing information in a sample of contracts for provision of autism diagnostic assessment services and ADHD services; and
  • a number of relevant academic papers, including, in particular, Realist evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Findings from a rapid realist review, which contains autism diagnostic assessment costs.

Written Question
Hallux Rigidus and Hallux Valgus: Hampshire
Monday 9th March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to provide funding for the treatment of (a) Hallux valgus and (b) Hallux rigidus in Hampshire.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Decisions on the funding and provision of treatment for hallux valgus and hallux rigidus in Hampshire are made locally by the NHS Hampshire and Isle of Wight Integrated Care Board (ICB), which is responsible for assessing the health needs of its population and commissioning services accordingly. This includes determining local clinical pathways, access criteria, and the availability of both surgical and non‑surgical interventions, based on the best available clinical evidence and local priorities.

NHS England does not provide condition‑specific national funding for these procedures. Instead, the ICB receives a general allocation to meet the healthcare needs of its local population. Within this, the ICB is expected to ensure that patients with foot and ankle conditions can access appropriate assessment, conservative management, and referral for surgery where clinically necessary.


Written Question
Buprenorphine: Hampshire
Tuesday 3rd March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to expand the rollout of long-acting injectable buprenorphine (LAIB) in i) Hampshire ii) Gosport.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Local authorities are responsible for commissioning drug and alcohol treatment services according to local need, and this includes the provision of long-acting injectable buprenorphine.

From 2026/27, all drug and alcohol treatment and recovery funding will be channelled through the Public Health Grant, with ringfenced funding for drug and alcohol treatment and recovery. This is the first multi-year settlement in over a decade and provides the certainty for local government to plan and invest for the medium term. Through the ringfenced funding, Hampshire will receive £10,999,940 in 2026/27, and indicative totals of £11,223,997 and £11,442,554 for 2027/28 and 2028/29 respectively.

The Department encourages local authorities to prioritise resourcing long-acting injectable buprenorphine prescribing if current provision is not adequate and has asked to see the specific planning assumptions and ambitions set out in the treatment plans shared with the Department.

The Department supports interventions to expand the provision of long-acting injectable buprenorphine. We are currently doing more analysis to understand cost-effectiveness, developing clinical guidance, and scoping how best to expand access to long-acting injectable buprenorphine further.


Written Question
Human Remains: Regulation
Tuesday 3rd March 2026

Asked by: Caroline Dinenage (Conservative - Gosport)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the additional cost of requiring the Human Tissue Authority to regulate the care of corpses throughout the death pathway including in funeral homes.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department has not made an assessment of the additional cost of requiring the Human Tissue Authority to regulate the care of the deceased throughout the death pathway, including in funeral homes.

The Government is considering the full range of options to strengthen and improve standards to safeguard the security and dignity of the deceased. In this context, an interim update on progress with our response to the Fuller Inquiry Phase 2 report was published 16 December 2025, and is available at the following link:

https://www.gov.uk/government/publications/fuller-inquiry-government-interim-update-on-phase-2-recommendations

We will provide a full response by summer 2026.